The CEEHRC Pod

In this final special episode of the CEEHRC podcast, we go behind the scenes with the 2025 CEEHRC Annual General Meeting organizers. They share the preparation, challenges, and teamwork that bring the event to life.

In this second special episode of the CEEHRC podcast, we meet the 2025 CEEHRC Annual General Meeting sponsors. They share their perspectives on innovation and collaboration, exploring the connections between academic research and industry.

In this special episode of the CEEHRC podcast, students and professors share their research, experiences, and highlights from the Annual CEEHRC Conference, offering perspectives from different stages of an academic career.

Dans cet épisode hors-série du podcast du CEEHRC, nous recevons Dr. Émilie Dubois, directrice d’Impackt Scientifique. Elle partage son parcours et sa vision du rôle de la communication et de la valorisation scientifique, en mettant en lumière les liens entre recherche, impact sociétal et diffusion des connaissances. Un échange inspirant pour mieux comprendre les enjeux de la science au-delà du laboratoire.

Dr. Rafaela Andrade is the Co-founder and CEO of Myomar Molecular, a Canadian biotechnology company at the forefront of muscle health monitoring. Rafaela’s scientific journey began at Dalhousie University, where she earned her PhD in the laboratory of Dr. Paola Marignani, focusing on the intersection of cancer and metabolism. Her transition from the bench to industry accelerated during her postdoctoral studies at the Creative Destruction Lab (CDL), where she was recognized nationally as a leading female biotech founder. It was there that she pioneered the technology behind Myomar, which utilizes molecular biomarkers to monitor and predict muscle health. In recognition of her impact on the industry, she was named the 2023 Outstanding Entrepreneur of the Year.

Dans cet épisode, Camille Souchet et Laureline Charrier ont le plaisir d’échanger avec Éléonore Charrier, Technical Application Scientist chez Illumina. À travers son parcours et son expérience, elle nous offre un éclairage concret sur les applications des technologies de séquençage, les enjeux du domaine, ainsi que les perspectives d’évolution dans le secteur de l'industrie. Un épisode enrichissant pour mieux comprendre les passerelles entre recherche, innovation et industrie.

Dr. Aida Minguez Menendez est conseillère en communication et transfert de connaissances au sein du regroupement de recherche Oplait, à la faculté de médecine vétérinaire de l'Université de Montréal. Dans cet épisode, co-animé par Camille Souchet et Laureline Charrier, elle nous partage son parcours, qui l’a menée du PhD à la communication scientifique. Elle revient sur les différentes missions qui composent son poste, mais aussi sur l’importance de la vulgarisation scientifique, des réseaux sociaux et de la circulation de l’information dans le milieu de la recherche.

Dr. David Cheishvili is Chief Innovation Officer at epiMedTech Global, affiliated with the Department of Oncology at McGill University in Montreal, and also holds leadership roles at NanoWellness Inc. and MTL Epitherapeutics Inc. Dr. David Cheishvili holds a PhD in Biochemistry and Molecular Biology from The Hebrew University. He is a molecular biologist and epigenetics researcher with over 25 years of experience spanning academia, clinical trials, and biotech innovation. He has co-invented patents in cancer detection and epigenetic age testing, led clinical trials and research in epigenetics, and published extensively on DNA methylation and diagnostics.

Have you ever wanted to sit down with three generations of scientists and have an honest conversation about research careers, the realities of doing a PhD, and the future of science?

Dr. Amélie Fradet-Turcotte is a Professor at Université Laval and a researcher at the CHU de Québec–Université Laval Research Centre. Her research explores how our cells maintain the integrity of their genome, especially in the context of viral infections like HPV. Using a powerful mix of biochemistry and molecular biology, her lab uncovers how viruses hijack our DNA repair machinery. Tune in if you’re curious about how viruses interact with this machinery, what happens when repair mechanisms fail, and how this all connects to cancer research. In our conversation, Dr. Fradet-Turcotte also shares a powerful message: you must try something to know whether you’ll like it or not. If you don’t try, you’ll never know!